ArticleTheranostics2024

Immunotherapeutic IL-6R and targeting the MCT-1/IL-6/CXCL7/PD-L1 circuit prevent relapse and metastasis of triple-negative breast cancer.

Aushia Tanzih Al Haq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.